Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Efficacy of IS-741 on spontaneous colitis in transgenic rat model

Oct. 2, 2002

PARP inhibitor GPI-6150 effective in rat model of colitis

Oct. 2, 2002

Tanabe AAI signs development and licensing agreements for first three compounds

Sep. 30, 2002

Patient enrollment completed in phase IIb renzapride trial in IBS

Sep. 26, 2002

Functional fatty acid compound tested in patients with NASH in U.S. trial

Sep. 26, 2002

First nucleotide analogue for HBV approved by FDA

Sep. 25, 2002

New anti-H. pylori agents identified by American researchers

Sep. 25, 2002

Deligoparin does not meet endpoints of pivotal study in ulcerative colitis

Sep. 20, 2002

Nautilus Biotech designs improved interferon alfa

Sep. 20, 2002

Wild-type and lamivudine-resistant hepatitis B virus susceptible to MCC-478

Sep. 19, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 9, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...